Hjem › Bløtvevssarkom › Massachusetts › Boston
Kliniske studier for Bløtvevssarkom i Boston, MA
18 studier for Bløtvevssarkom søker deltakere på steder i og rundt Boston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
- Dana-Farber Cancer Institute, Boston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
- Dana-Farber Cancer Institute - Oncology Department, Boston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RekruttererFase 1/2
- Dana Farber Cancer Institute., Boston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
RekruttererFase 1
- Dana-Farber Cancer Institute, Boston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RekruttererFase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
RekruttererFase 1
- Dana-Farber Cancer Institute, Boston
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
RekruttererFase 1
- Dana-Farber Cancer Institute, Boston
Serial MRI Scans During Radiation Therapy
Rekrutterer
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention
Rekrutterer
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
RekruttererFase 1/2
- Dana Farber Cancer Institute, Boston
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
RekruttererFase 1/2
- Dana Farber Cancer Institute, Boston
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
RekruttererObservasjonsstudie
- Brigham and Women's Hospital, Boston
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
RekruttererObservasjonsstudie
- Dana-Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- Massachusetts General Hospital,, Boston
Video Education With Result Dependent dIsclosure
Rekrutterer
- Dana Farber Cancer Institute, Boston
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
RekruttererFase 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
REtroperitoneal SArcoma Registry: an International Prospective Initiative
RekruttererObservasjonsstudie
- Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston
Bløtvevssarkom-studier i andre byer
- Houston, TX32 studier
- New York City, NY19 studier
- St. Louis, MO14 studier
- Columbus, OH13 studier
- Los Angeles, CA13 studier
- Washington, DC12 studier
- Memphis, TN11 studier
- Philadelphia, PA10 studier
- Rochester, MN9 studier
- Nashville, TN9 studier
- Aurora, CO9 studier
- Queens, NY9 studier
Andre studier i Boston
- Brystkreft111 studier
- Ikke-småcellet lungekreft90 studier
- Kreft (alle typer)86 studier
- Kolorektal kreft63 studier
- Metastatisk kreft63 studier
- Lungekreft62 studier
- Eggstokkreft61 studier
- Prostatakreft59 studier
- Depresjon52 studier
- Endometriekreft50 studier
- Hjertesvikt44 studier
- Akut myelogen leukemi44 studier
Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.